0001882782-24-000001.txt : 20240814 0001882782-24-000001.hdr.sgml : 20240814 20240814122606 ACCESSION NUMBER: 0001882782-24-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240814 DATE AS OF CHANGE: 20240814 EFFECTIVENESS DATE: 20240814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Odyssey Therapeutics, Inc. CENTRAL INDEX KEY: 0001882782 ORGANIZATION NAME: IRS NUMBER: 863384382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-499898 FILM NUMBER: 241205787 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (212) 841-1000 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 D/A 1 primary_doc.xml X0708 D/A LIVE 0001882782 Odyssey Therapeutics, Inc. 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 (212) 841-1000 DELAWARE None None Corporation true 2021 Gary D. Glick 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Executive Officer Director Carl Gordon 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Jill Carroll 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Valerie Odegard 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Charles M. Baum 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Jeffrey Leiden 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Lorence Kim 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Timothy Walbert 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Ian Smith 51 Sleeper Street Suite 800 Boston MA MASSACHUSETTS 02210 Director Biotechnology Decline to Disclose 06b true 0001882782-23-000001 2023-10-25 false true false 0 121080000 117210000 3870000 false 43 0 0 0 false Odyssey Therapeutics, Inc. /s/ Gary D. Glick Gary D. Glick President & CEO 2024-08-14